TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07813130: A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosomes in Patients With Moderate to Severe Acute Ischemic Stroke

Sponsor: Aruna Bio, Inc. · Phase: PHASE1 · Area: CNS_NEUROLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$580,448

Rescue Site Savings

+$395,760

Unlock Full NCT07813130 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07813130 Rescue Dossier →